Evidence map›Paper›PMID 39963822›Full record

ReviewChemMedChem2025

Metal-Catalyzed Cross-Coupling for the Synthesis of β-Lactam Drugs and Related Chemical Probes.

Jules Bresson, Katie Burke, Mélanie Ethève-Quelquejeu, Laura Iannazzo, Kevin Cariou

Abstract readReview
In one paragraph

Review in ChemMedChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jules BressonInstitute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, Chimie ParisTech, PSL University, CNRS, 11 rue Pierre et Marie Curie, 75005, Paris, France.ORCID https://orcid.org/0009-0004-7774-8137
Katie BurkeLaboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, Université Paris Cité, CNRS, F-75006, Paris, France.
Mélanie Ethève-QuelquejeuLaboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, Université Paris Cité, CNRS, F-75006, Paris, France.ORCID https://orcid.org/0000-0002-4105-3243
Laura IannazzoLaboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, Université Paris Cité, CNRS, F-75006, Paris, France.ORCID https://orcid.org/0000-0002-2181-4885
Kevin CariouInstitute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, Chimie ParisTech, PSL University, CNRS, 11 rue Pierre et Marie Curie, 75005, Paris, France.ORCID https://orcid.org/0000-0002-5854-9632

Funding

Chimie ParisTech-PSL UniversityCNRSInstitut Universitaire de FranceNarrow Spectrum Antibiotics to Fight the Emergence of Bacterial Resistance project 20-PAMR-0007Université Paris-Cité
6 · The paper itself

Abstract

Antimicrobial resistance is a major public health threat, due to the emergence of new bacterial strains not responding to classical antibiotics. This review focuses on the use of transition metal cross-coupling strategies used to access new β-lactam derivatives, the most well-known and commonly used antibiotics. This manuscript covers the seminal studies for the synthesis of antibiotics up to the current need of accessing specific probes (by functionalizing existing drugs), crucial for the detection of resistances. These strategies also allow the linkage of a cargo to a β-lactam antibiotic for selective release for either therapeutic effect or for diagnostic purposes (in the case of probes), which will be explained in this article.

Indexed as

Anti-Bacterial Agentsbeta-LactamsTransition ElementsCatalysisMolecular StructureAnti-Bacterial Agentsbeta-LactamsTransition Elementsantibioticscarbapenemscephalosporinschemical probesmetal catalyzed cross-couplingβ-lactamase

Identifiers

PMID39963822
PMCPMC12058247

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.